Abstract
A number of linkage studies have previously implicated the region of chromosome 13q34 in schizophrenia. Chumakov and colleagues (2002) identified a gene complex called G72 (now termed d-amino acid oxidase activator: DAOA)/G30 in this region and performed association analyses of the DAOA/G30 as well as the d-amino-acid oxidase (DAAO) gene with schizophrenia. DAAO oxidizes d-serine, a potent activator of the N-methyl-d-aspartate (NMDA) type glutamate receptor in the human brain whereas the DAOA protein is considered an activator of DAAO. The interaction of these two genes has thus been implicated in the NMDA receptor regulation pathway in schizophrenia. To date, several studies have shown a relatively consistent positive association between schizophrenia and DAOA/G30, but not with DAAO. The aim of our study was to further evaluate the contributions of these genes to the susceptibility to schizophrenia using two different sample sets. Our sample consisted of 168 matched case-control pairs as well as a family-based sample (n=113) for transmission disequilibrium test. Significant associations between the DAOA/G30 M-7 and M-18 polymorphisms and schizophrenia were observed in our case-control sample whereas no associations were observed for DAAO markers. We also observed significant or suggestive transmission disequilibrium for DAOA/G30 M-7, M-23, and M-24 to probands with schizophrenia in our family-based sample. Subsequent analysis of haplotypes made up of four DAOA/G30 markers, one marker selected from each of two linkage disequilibrium blocks that were observed in our sample as well as both ends (M-7 and M-25), were also associated with schizophrenia. Our data provide further evidence that the DAOA/G30 locus may play a role in the pathophysiology of schizophrenia. Although no direct link to genetic polymorphism in these genes and NMDA receptor function has been revealed, the present findings support previous reports implicating DAOA/G30 as susceptibility genes for schizophrenia. Further research is warranted to determine the functional variation underlying these findings and to relate this to the pathophysiology of schizophrenia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Addington A. M., Gornick M., Sporn A. L., et al. (2004) Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol. Psychiatry 55, 976–980.
Badner J. A. and Gershon E. S. (2002) Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry 7, 405–411.
Barrett J. C., Fry B., and Maller J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265.
Chen Y. S., Akula N., and Detera-Wadleigh S. D. (2004) Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol. Psychiatry 9, 87–92.
Chumakov I., Blumenfeld M., Guerassimenko O., et al. (2002) Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. USA 99, 13,675–13,680.
Detera-Wadleigh S. D. and McMahon F. J. (2006) G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 60, 106–114.
Dudbridge F. (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25, 115–121.
First M. B., Spitzer R. L., Gibbon M., and Williams J. B. W. (1997) Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition With Psychotic Screen. Biometrics Research, New York State Psychiatric Institute, New York.
Geyer M. A., Krebs-Thomson K., Braff D. L., Swerdlow N. R. (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156, 117–154.
Goldberg T. E., Straub R. E., and Callicott J. H. (2006) The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 31, 2022–2032.
Harrison P. J. and Weinberger D. R. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 40–68.
Hattori E., Liu C., Badner J. A., et al. (2003) Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am. J. Hum. Genet. 72, 1131–1140.
Korostishevsky M., Kaganovich M., Cholostoy A., et al. (2004) Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol. Psychiatry 56, 169–176.
Lahiri D. K. and Nurnberger J. I. Jr. (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19, 5444.
Millan M. J. (2005) N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 179, 30–53.
Moreno S., Nardacci R., Cimini A., and Ceru M. P. (1999) Immunocytochemical localization of D-amino acid oxidase in rat brain. J. Neurocytol. 28, 169–185.
Morris B. J., Cochran S. M., and Pratt J. A. (2005) PCP: from pharmacology to modelling schizophrenia. Curr. Opin. Pharmacol. 5, 101–106.
Mothet J. P., Parent A. T., Wolosker H., et al. (2000) D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA 97, 4926–4931.
Mulle J. G., Chowdari K. V., Nimgaonkar V., and Chakravarti A. (2005) No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families. Mol. Psychiatry 10, 431–433.
Müller D. J., Sicard T., King N., De Luca V., and Kennedy J. L. (2005) Further evidence that the DAOA (G72) gene is a risk factor for bipolar disorder: results from a family based association study. Am. J. Med. Genet. 138B, 28.
Schulze T. G., Ohlraun S., Czerski P. M., et al. (2005) Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am. J. Psychiatry 162, 2101–2108.
Schumacher J., Jamra R. A., Freudenberg J., et al. (2004) Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol. Psychiatry 9, 203–207.
Toro C. T., Kasher P. R., and Deakin J. F. W. (2004) Altered D-serine metabolism in schizophrenia? A post-mortem study using Stanley Consortium brains. Schizophr. Res. 67(Suppl.), 125.
Zou F., Li C., and Duan S. (2005) A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population. Schizophr. Res. 73, 257–261.
Wang X., He G.., Gu N., et al. (2004) Association of G72/G30 with schizophrenia in the Chinese population. Biochem. Biophys. Res. Commun. 319, 1281–1286.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shinkai, T., De Luca, V., Hwang, R. et al. Association analyses of the DAOA/G30 and d-amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia. Neuromol Med 9, 169–177 (2007). https://doi.org/10.1007/BF02685890
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02685890